Method for operating a light therapy progress measurement device, processor, and light therapy system
The phototherapy progress measuring method corrects for re-accumulation of fluorescent agents by using reference data to accurately determine treatment completion and adjust light intensity, addressing the non-monotonic attenuation of fluorescence intensity during phototherapy.
Patent Information
- Application Number
- JP2023517006
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2021-04-30
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2041-04-30
AI Technical Summary
The fluorescence intensity of a fluorescent agent does not attenuate monotonically in all affected areas, leading to difficulties in accurately determining the progress of phototherapy, as it may increase during treatment due to re-accumulation, making it challenging to judge completion based solely on fluorescence intensity.
A phototherapy progress measuring method and device that utilizes a photodetection section to detect fluorescence intensity, calculates progress information using reference data and preset data to correct for re-accumulation, and adjusts treatment light based on integrated values and coincidence of fluorescence changes, enabling real-time measurement of phototherapy progress.
Accurately measures phototherapy progress in real-time by correcting for re-accumulation of the fluorescent agent, allowing for precise determination of treatment completion and optimizing treatment light intensity.
Smart Images

Figure 0007581497000001 
Figure 0007581497000002 
Figure 0007581497000003
Abstract
Description
[Technical field]
[0001] The present invention relates to a phototherapy progress measurement method, a phototherapy progress measurement device, and a phototherapy system. [Background technology]
[0002] Conventionally, phototherapy is known in which therapeutic light is applied to an affected area to excite a fluorescent agent within the affected area, thereby treating the affected area (see, for example, Patent Document 1). As the phototherapy progresses, the fluorescent agent is consumed, and the intensity of the fluorescence generated in the affected area attenuates accordingly. In Patent Document 1, irradiation of the therapeutic light to the affected area is terminated when the intensity of the fluorescence falls below a predetermined threshold. [Prior art documents] [Patent documents]
[0003] [Patent Document 1] JP 2006-167046 A Summary of the Invention [Problem to be solved by the invention]
[0004] The fluorescence intensity of the fluorescent agent does not necessarily decay monotonically at the same rate in all affected areas, but shows various behaviors for each affected area. For example, the decay rate of the fluorescence intensity differs for each patient. In order to appropriately determine the timing to end phototherapy, the fluorescence intensity at the end of phototherapy is important. However, the inventors discovered that the fluorescence intensity at the end of phototherapy does not decrease sufficiently even if the irradiation of excitation light is continued, and may even change from attenuation to increase during the period when the fluorescence intensity is low. As a result, the consumption of the fluorescent agent in the affected area, i.e., the progress of the phototherapy, is not necessarily accurately reflected. Therefore, it is difficult to grasp the exact progress of the phototherapy in real time based only on the fluorescence intensity from the fluorescent agent.
[0005] The present invention has been made in consideration of the above-mentioned circumstances, and aims to provide a phototherapy progress measurement method, a phototherapy progress measurement device, and a phototherapy system that can accurately measure the progress of phototherapy on an affected area in real time. [Means for solving the problem]
[0006] In order to achieve the above object, the present invention provides the following means. One aspect of the present invention is a phototherapy progress measurement device for measuring the progress of phototherapy of an affected area using a fluorescent drug. Operation of the device a first fluorescence intensity, which is an intensity of fluorescence generated in the affected area by irradiating the affected area with therapeutic light, By the light detection section Detecting, and Detected by the light detection unit The first fluorescence intensity and associated with said fluorescent agent Reference Data and The progress information showing the progress of the phototherapy of the affected area is In the calculation section calculating the reference data based on a fluorescence intensity associated with the fluorescent agent in the affected area not involved in the light treatment. Operation of the device This is the method.
[0007] Another aspect of the present invention is to measure the progress of phototherapy of a diseased area with a fluorescent drug. Processor the optical detector detects a first fluorescence intensity, which is an intensity of fluorescence generated in the affected area by irradiating the affected area with therapeutic light; and a calculator calculates progress information representing a progress of phototherapy on the affected area using the first fluorescence intensity and reference data, wherein the reference data is determined based on a fluorescence intensity associated with the fluorescent agent in the affected area that is not involved in the phototherapy. Processor It is.
[0008] Another aspect of the present invention is a phototherapy system for irradiating an affected area with therapeutic light and phototherapy the affected area with a fluorescent agent, the phototherapy system comprising: a therapeutic light source for outputting the therapeutic light; a therapeutic light irradiating unit for irradiating the affected area with the therapeutic light; Processor and a notification unit that notifies the result of the determination by the determination unit of the phototherapy progress measurement device. Effect of the Invention
[0009] According to the present invention, it is possible to obtain an effect that the accurate progress of phototherapy on an affected area can be measured in real time. [Brief description of the drawings]
[0010] [Figure 1] 1 is an overall configuration diagram of a phototherapy progress measurement device and a phototherapy system according to a first embodiment. [Diagram 2] FIG. 13 is a diagram showing an example of the change over time in fluorescence intensity of an affected area during phototherapy. [Diagram 3] FIG. 13 is a diagram illustrating the fluorescence intensity of an affected area. [Figure 4] FIG. 4 is a diagram showing a plurality of preset data stored in a storage unit. [Diagram 5] 11A and 11B are diagrams illustrating a method of calculating an integrated value using preset data. [Figure 6] 4 is a flowchart showing the operation of the phototherapy progress measurement device and the phototherapy system of FIG. 1. [Figure 7] FIG. 11 is an overall configuration diagram of a phototherapy progress measurement device and a phototherapy system according to a second embodiment. [Figure 8] FIG. 13 is a diagram showing an example of changes over time in the amount of change per unit time of each of a first fluorescent intensity and a second fluorescent intensity. [Figure 9] 8 is a flowchart showing the operation of the phototherapy progress measurement device and the phototherapy system of FIG. 7. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0011] (First embodiment) A phototherapy progress measurement method, a phototherapy progress measurement device, and a phototherapy system according to a first embodiment of the present invention will be described with reference to the drawings. As shown in Fig. 1, the phototherapy system 100 according to this embodiment is an endoscope system that performs phototherapy on an affected area A using a photoresponsive fluorescent agent while observing the affected area A using an endoscope 1. The affected area A is, for example, a cancer of the upper digestive tract such as the esophagus. The fluorescent agent is a fluorescent molecule that has the property of accumulating in the affected area A, and is activated by excitation with excitation light to exert a therapeutic effect. The fluorescent agent is, for example, a panitumumab-IR700 complex or a hematoporphyrin derivative.
[0012] The phototherapy system 100 includes an endoscope 1 for observing an affected area A inside the body, an illumination light source 2 for generating illumination light L1 for illuminating the affected area A, a therapeutic light source 3 for generating therapeutic light L2 for treating the affected area A, a probe (therapeutic light irradiator) 4 that is inserted into the body via the endoscope 1 and irradiates the affected area A with the therapeutic light L2, an image processor 5 for processing endoscopic images, and a display (notification unit) 6 for displaying the endoscopic images. An endoscope processor 101 is connected to the proximal end of the endoscope 1.
[0013] The endoscope 1 has a long, flexible or rigid scope 7 and an image acquisition unit 8. The scope 7 is provided with a treatment tool channel 7a that penetrates the scope 7 in the longitudinal direction. In addition, an illumination window 7b and a light receiving window 7c are provided on the distal end surface of the scope 7. The endoscope 1 emits illumination light L1 supplied from the illumination light source 2 from the illumination window 7b toward the affected area A. In addition, the endoscope 1 receives the illumination light L1 reflected by the affected area A at the light receiving window 7c, and acquires an endoscopic image of the affected area A by the image acquisition unit 8 having an image sensor.
[0014] The illumination light source 2 outputs white illumination light L1. The therapeutic light source 3 outputs therapeutic light L2, which is excitation light having an excitation wavelength of the fluorescent agent. The probe 4 is a long optical fiber probe having an optical fiber for guiding the therapeutic light L2, and is inserted into the treatment instrument channel 7a. The proximal end of the probe 4 is connected to the therapeutic light source 3, and the therapeutic light L2 is irradiated from the distal end of the probe 4 to the affected area A. The image processing unit 5 receives the endoscopic image from the image acquisition unit 8, processes the endoscopic image as necessary, and outputs the endoscopic image to the display unit 6. The display unit 6 is an arbitrary display device such as a liquid crystal display.
[0015] FIG. 2 shows the experimental results of phototherapy using a panitumumab-IR700 conjugate, which is a conjugate of a molecular target antibody and a fluorescent substance. As the phototherapy progresses, the fluorescent agent in the affected area A is consumed, and the fluorescence intensity F attenuates accordingly. Therefore, a doctor can recognize that the phototherapy is progressing based on the attenuation of the fluorescence intensity F. However, the fluorescence intensity F does not necessarily attenuate monotonically as in the curve a, but may increase at the end of the phototherapy as in the curves b and c. In addition, the rate of attenuation of the fluorescence intensity F also differs depending on the conditions, etc. Therefore, it is difficult to determine whether the required amount of the fluorescent agent administered to the affected area A has been consumed, that is, whether the phototherapy has been completed, based only on the fluorescence intensity F.
[0016] One of the reasons why the fluorescence intensity F does not decay monotonically is thought to be the reaccumulation of the fluorescent agent during phototherapy. That is, after a sufficient amount of the fluorescent agent is administered to a patient by intravenous injection, a part of the fluorescent agent is not taken up by the affected area A but recirculates with the blood, and at the end of the phototherapy, it reaccumulates in the affected area A, causing an increase in the fluorescence intensity F. Therefore, as shown in Figure 3, the fluorescence intensity F (see curve b) is the sum of the fluorescence intensity generated by the fluorescent agent that has already accumulated in the affected area A before the start of phototherapy (see curve d) and the fluorescence intensity generated by the fluorescent agent that reaccumulates in the affected area A after the start of phototherapy (see curve e). In period I, the fluorescence of the fluorescent agent that had already accumulated in the affected area A before phototherapy is dominant, and a high therapeutic effect is obtained. In period II, the fluorescence of the fluorescent agent that had already accumulated and the fluorescence of the re-accumulated fluorescent agent are mixed, and the therapeutic effect is slight. In period III, the fluorescence of the re-accumulated fluorescent agent is dominant, and almost no phototherapeutic effect derived from the fluorescent agent that had already accumulated in the affected area A is obtained.
[0017] The phototherapy system 100 includes a phototherapy progress measuring device 10 that measures the progress of phototherapy on the affected area A to assist a doctor in determining whether or not to terminate phototherapy on the affected area A. As shown in Fig. 1, the phototherapy progress measuring device 10 includes a light detection unit 11 that detects a fluorescence intensity (first fluorescence intensity) F, an intensity data generating unit 12 that stores the detected fluorescence intensity F in chronological order, a storage unit 13 that stores a plurality of preset data prepared in advance, a calculation unit 14 that calculates progress information indicating the progress of phototherapy on the affected area A, a determination unit 15 that determines whether or not phototherapy on the affected area A has been completed based on the progress information, and a therapeutic light adjustment unit 16 that adjusts the intensity of the therapeutic light L2.
[0018] The phototherapy progress measurement device 10 has at least one processor such as a central processing unit, and a storage device such as a RAM (random access memory) and a ROM (read-only memory). The processor executes processes according to the programs stored in the storage device, thereby realizing the processes of the intensity data generating unit 12, the calculating unit 14, the determining unit 15, and the therapeutic light adjusting unit 16, which will be described later. The storage unit 13 is made of a storage device.
[0019] A barrier filter 7d that selectively transmits the fluorescence Lf and blocks light in a wavelength range different from that of the fluorescence Lf is provided on the tip surface of the scope 7. The light detection unit 11 detects the intensity F of the fluorescence Lf that has transmitted through the barrier filter 7d, and transmits the fluorescence intensity F to the intensity data generation unit 12. For example, the light detection unit 11 has an imaging element provided in the endoscope processor 101 or the scope 7, and obtains a fluorescence image including information on the fluorescence intensity F. The fluorescence image may be transmitted to the display unit 6 via the image processing unit 5 and displayed on the display unit 6. The light detection unit 11 may have any type of photodetector other than an imaging element.
[0020] The intensity data generating unit 12 generates intensity data by storing the fluorescence intensity F in chronological order. For example, the intensity data generating unit 12 stores the average luminance value of the fluorescence image as the intensity value. The intensity data is data that represents the change over time in the fluorescence intensity F, such as the curves a, b, and c shown in Figs. 2 and 3. As shown in FIG. 4, the multiple preset data D1, D2, D3, ... stored in advance in the storage unit 13 are data that represent the change over time in the fluorescence intensity of the fluorescent agent due to irradiation with the therapeutic light L2, but do not include the fluorescence intensity of the re-accumulated fluorescent agent.
[0021] For example, the preset data D1, D2, D3, ... are obtained by irradiating the therapeutic light L2 on a fluorescent agent in a test tube and detecting and storing the fluorescent intensity over time, and the data are stored in the memory unit 13 by the operator before performing phototherapy. The manner in which the fluorescent intensity of the affected area A attenuates varies depending on various parameters such as the measurement distance, the concentration of the fluorescent agent, and the irradiation intensity of the therapeutic light L2. Thus, a plurality of preset data D1, D2, D3, ... obtained under different parameters are stored in the memory unit 13.
[0022] The calculation unit 14 judges in real time whether the fluorescence intensity F is attenuating or not, and when the fluorescence intensity F stops attenuating for the first time, starts calculating the progress information using the intensity data and preset data. Specifically, each time the light detection unit 11 detects the fluorescence intensity F, the calculation unit 14 calculates the amount of change ΔF per unit time of the fluorescence intensity F at that time. For example, at time t i (i=1,2,3,…) is the fluorescence intensity F(t i ) is detected, the change amount ΔF(t i ) is the fluorescence intensity F(t i ) and the previous time t i-1 The fluorescence intensity F(t i-1 ) is calculated using the following formula: ΔF(t i )=(F(t i )-F(t i-1 )) / (t i -t i-1 )
[0023] If the amount of change ΔF is negative, i.e., if the fluorescence intensity F is attenuating, the calculation unit 14 does not calculate the progress information. If the amount of change ΔF is not negative, i.e., if the amount of change ΔF is zero or positive and the fluorescence intensity F is constant or increasing, the calculation unit 14 executes the process described below to calculate the progress information.
[0024] FIG. 5 illustrates a method for calculating progress information using intensity data and preset data. The progress information is an integrated value I obtained by integrating the amount of change in the fluorescence intensity F per unit time from the start of treatment to the present time. Fig. 5 shows integrated data indicating the change over time in the integrated value I. The integrated value I indicates the amount of fluorescent agent consumed in the affected area A by irradiating the affected area A with the therapeutic light L2, i.e., the progress of the phototherapy on the affected area A.
[0025] 5, the calculation unit 14 selects one preset data most similar to the intensity data from among the multiple preset data as reference data. Specifically, the calculation unit 14 compares the curve of the time change of the fluorescence intensity F in the intensity data with the curve of the time change of the fluorescence intensity G in the multiple preset data, and selects the preset data with the curve most similar in shape to the curve of the intensity data. Next, the calculation unit 14 calculates a correction change amount ΔF' after it is determined for the first time that the change amount ΔF is not negative by using the reference data, and calculates an integrated value I by using the correction change amount ΔF' and the change amount ΔF before it is determined for the first time that the change amount ΔF is not negative. k is the time when it is first determined that the amount of change ΔF is not negative.
[0026] The corrected amount of change ΔF' corresponds to the amount of change ΔF corrected to remove the amount of change per unit time in the fluorescence intensity of the fluorescent agent that re-accumulates in the affected area A, and is the net amount of change in the fluorescence intensity of the fluorescent agent that has already accumulated in the affected area A that is expected in the absence of re-accumulation of the fluorescent agent in the affected area A. If the integrated value I is calculated using only the amount of change ΔF, the integrated value I will be affected by the fluorescence intensity of the re-accumulating fluorescent agent, and will no longer, for example, monotonically increase, as shown by the dashed line in the integrated data in Fig. 5. In contrast, after it is first determined that the amount of change ΔF is not negative, it is possible to calculate an integrated value I from which the influence of the fluorescence intensity of the re-accumulating fluorescent agent has been eliminated, as shown by the solid line in the integrated data in Fig. 5.
[0027] Specifically, the calculation unit 14 calculates the attenuation rate α per unit time of the fluorescence intensity G at a time corresponding to the current time as the correction coefficient. i The decay rate α(t i ) at time t i ,t i-1 Fluorescence intensity G(t i ),G(t i-1 ) is calculated using the following formula: α(t i )=1 - G(t i ) / G(t i-1 ) Next, the calculation unit 14 calculates the fluorescence intensity F(t i ) detected just before the i-1 ) with decay rate α(t i ) to get the current time t i The correction change amount ΔF'(t i Next, the calculation unit 14 calculates the correction change amount ΔF′(t i ) at time t i-1 The integrated value I(t i-1 ) to obtain the integrated value I(t i The calculation unit 14 calculates the attenuation rate α, the corrected change amount ΔF′, and the integrated value I each time the fluorescence intensity F is detected.
[0028] The judgment unit 15 compares the integrated value I with a predetermined threshold value Th. If the integrated value I is equal to or less than the threshold value Th, the judgment unit 15 outputs a judgment result indicating that the integrated value I is equal to or less than the predetermined threshold value. If the integrated value I is greater than the threshold value Th, the judgment unit 15 outputs a judgment result indicating that the integrated value I has exceeded the predetermined threshold value. The judgment result of the judgment unit 15 is sent to the therapeutic light adjustment unit 16 and is displayed on the display unit 6 to inform the doctor.
[0029] The therapeutic light adjustment unit 16 adjusts the intensity of the therapeutic light L2 irradiated to the affected area A based on the result of the judgment by the judgment unit 15. Specifically, if it is judged that the intensity is equal to or less than the predetermined threshold, the therapeutic light adjustment unit 16 maintains the output of the therapeutic light L2 from the therapeutic light source 3 to maintain the intensity of the therapeutic light L2 irradiated to the affected area A. On the other hand, if it is judged that the intensity exceeds the predetermined threshold, the therapeutic light adjustment unit 16 controls the therapeutic light source 3 to reduce or stop the output of the therapeutic light L2 from the therapeutic light source 3, thereby reducing the intensity of the therapeutic light L2 irradiated to the affected area A.
[0030] Next, the operation of the phototherapy system 100 and the phototherapy progress measurement device 10 will be described with reference to FIG. In order to perform phototherapy on the affected area A using the phototherapy system 100, a fluorescent agent is first administered to the affected area A, for example, by intravenous injection into the patient. After the intravenous injection, it takes time for the fluorescent agent to accumulate in the affected area A. After a predetermined time (for example, 24 hours) has elapsed since the intravenous injection, the doctor turns on the illumination light source 2, inserts the endoscope 1 into the patient's body while observing the endoscopic image displayed on the display unit 6, and positions the tip of the endoscope 1 near the affected area A. Next, the doctor inserts the probe 4 into the patient's body via the treatment tool channel 7a of the endoscope 1, positioning the tip of the probe 4 near the affected area A, and turns on the treatment light source 3. This starts irradiation of the therapeutic light L2 from the tip of the probe 4 to the affected area A, and phototherapy of the affected area A begins (step S1).
[0031] During phototherapy, the doctor confirms the progress of phototherapy based on the attenuation of the fluorescence intensity F of the affected area A in the endoscopic image displayed on the display unit 6. However, since the fluorescence intensity F is affected by the fluorescent agent that reaccumulates in the affected area A during phototherapy, the fluorescence intensity F does not necessarily accurately represent the progress of phototherapy. Therefore, it is difficult to determine whether phototherapy has been completed based only on the fluorescence intensity F.
[0032] According to this embodiment, a phototherapy progress measurement method is executed by the phototherapy progress measurement device 10 during phototherapy. The phototherapy progress measurement method includes steps S2 and S11 of detecting the intensity F of fluorescence Lf generated in the affected area A by irradiation with the therapeutic light L2, steps S3 and S12 of storing the fluorescence intensity F and generating intensity data representing the change in the fluorescence intensity F over time, steps S4 and S5 of determining the amount of change ΔF in the fluorescence intensity F, steps S6 to S8 of calculating progress information representing the progress of the phototherapy, and step S9 of determining whether the phototherapy on the affected area A has been completed based on the progress information.
[0033] After the start of phototherapy, the photodetector 11 detects the fluorescence intensity F (step S2), and the intensity data generator 12 stores the fluorescence intensity F in chronological order to generate intensity data (step S3). Next, the calculator 14 calculates the amount of change ΔF in the fluorescence intensity F per unit time (step S4), and determines whether the amount of change ΔF is negative, that is, whether the fluorescence intensity F is attenuating monotonically (step S5). If the amount of change ΔF is negative (YES in step S5), steps S2 to S4 are repeated.
[0034] If the amount of change ΔF is not negative (NO in step S5), the calculation unit 14 calculates progress information of the affected area A using the intensity data and the reference data (steps S6 to S8). Specifically, from among a plurality of preset data, the preset data most similar to the intensity data is selected as the reference data (step S6). Next, the calculation unit 14 calculates a corrected amount of change ΔF' of the fluorescence intensity F using the reference data, and calculates an integrated value I, which is progress information, using the amount of change ΔF calculated in step S4 and the corrected amount of change ΔF'.
[0035] Next, the integrated value I is compared with a predetermined threshold value Th by the judgment unit 15 (step S9). If it is judged that the integrated value I is equal to or less than the threshold value Th (NO in step S9), information indicating that the phototherapy is not yet completed is displayed on the display unit 6, thereby informing the doctor that the phototherapy is not yet completed (step S10). Thereafter, the detection of the fluorescence intensity F, the generation of the intensity data, and the calculation of the progress information in steps S11, S12, S7, and S8 are repeated until it is judged that the integrated value I is equal to or less than the threshold value Th.
[0036] If it is determined that the integrated value I is greater than the threshold value Th (YES in step S9), the display unit 6 displays information indicating the completion of the phototherapy, thereby informing the doctor of the completion of the phototherapy (step S13). In addition, the intensity of the therapeutic light L2 irradiated to the affected area A is reduced by the therapeutic light adjustment unit 16 (step S14).
[0037] The doctor judges whether or not to end the phototherapy based on the judgment result displayed on the display unit 6. Specifically, if the judgment result indicates that the amount of radiation is equal to or less than the predetermined threshold Th, the doctor continues to irradiate the therapeutic light L2 to the affected area A. On the other hand, if the judgment result indicates that the amount of radiation exceeds the predetermined threshold Th, the doctor turns off the therapeutic light source 3 to end the irradiation of the therapeutic light L2 to the affected area A, thereby ending the phototherapy of the affected area A.
[0038] As described above, it is difficult for a doctor to determine whether phototherapy is completed based only on the fluorescence intensity F at the affected area A during phototherapy. According to this embodiment, a plurality of preset data D1, D2, D3, ... are stored in the storage unit 13. The preset data D1, D2, ... are data on the fluorescence intensity of the fluorescent agent that monotonically decreases as a result of irradiation with the therapeutic light L2, and do not include the fluorescence intensity of the fluorescent agent that re-accumulates. In other words, the preset data D1, D2, D3, ... are models of typical time changes in the fluorescence intensity F at the affected area A due to irradiation with the therapeutic light L2 when the fluorescent agent does not re-accumulate at the affected area A during phototherapy.
[0039] By using any of the preset data D1, D2, D3, ..., a corrected change amount ΔF' is calculated, excluding the change amount per unit time of the fluorescence intensity of the re-accumulating fluorescent agent. Then, using the corrected change amount ΔF', an integrated value I that represents the accurate consumption amount of the fluorescent agent consumed by the phototherapy can be calculated as progress information, and the accurate progress of the phototherapy can be measured. In addition, it is possible to accurately determine whether the phototherapy has been completed based on the progress information.
[0040] In addition, the fluorescence intensity F is a parameter directly related to the amount of the fluorescent agent consumed in the affected area A, and progress information can be calculated in real time from the fluorescence intensity F. This makes it possible to accurately measure the progress of phototherapy in real time and to determine in real time whether or not the phototherapy has been completed. When the progress of phototherapy is indirectly measured using information other than the fluorescence intensity, it is difficult to measure the progress of phototherapy in real time.
[0041] In this embodiment, the corrected change amount ΔF' is calculated by multiplying the fluorescence intensity F by the attenuation rate α calculated from the reference data, but the method of calculating the corrected change amount ΔF' is not limited to this, and any calculation method can be used as long as it can calculate the net change amount ΔF' resulting from the fluorescent drug that has already accumulated in the affected area, excluding the change amount resulting from the re-accumulating fluorescent drug.
[0042] In one variant, after the first determination that the fluorescence intensity F does not decay, the fluorescence intensity G(t i ) per unit time change ΔG(t i ) is corrected by the change amount ΔF'(t i ) may also be used. In another variant, after the first determination that the fluorescence intensity F does not decay, the fluorescence intensity G(t i ) is the fluorescence intensity F(t i That is, the fluorescence intensity F of the intensity data after it is determined for the first time that the fluorescence intensity F does not attenuate is replaced with the fluorescence intensity G of the reference data, and the change amount ΔG of the fluorescence intensity G per unit time is calculated as the corrected change amount ΔF'. According to these modified examples, the corrected change amount ΔF' is predicted only from the reference data, so that after it is first determined that the fluorescence intensity F is not attenuating, there is no need to detect and store the fluorescence intensity F. Therefore, the process for calculating the progress information can be simplified.
[0043] Second embodiment Next, a phototherapy progress measurement method, a phototherapy progress measurement device, and a phototherapy system according to a second embodiment of the present invention will be described with reference to the drawings. The phototherapy system 200 according to this embodiment differs from the phototherapy system 100 according to the first embodiment in that the phototherapy progress measurement device 20 acquires second fluorescence intensity data, which is the fluorescence intensity of the re-accumulated fluorescent agent, as reference data, and calculates progress information using the second fluorescence intensity data. In this embodiment, differences from the first embodiment will be described, and components common to the first embodiment will be denoted by the same reference numerals and description thereof will be omitted.
[0044] As shown in FIG. 7, the phototherapy system 200 includes an endoscope 1, an illumination light source 2, a treatment light source 3, a probe 4, an image processor 5, a display unit 6, and a phototherapy progress measuring device 20. The phototherapy progress measurement device 20 includes a light detection unit 11 , a calculation unit 14 , a determination unit 15 , and a therapeutic light adjustment unit 16 .
[0045] In this embodiment, the therapeutic light adjustment unit 16 switches the output of the therapeutic light source 3 between a first high output and a second low output, thereby switching the light irradiated to the affected area A between the therapeutic light L2 and the measurement light L3. The therapeutic light L2 is light having a first intensity necessary for phototherapy. The fluorescent agent emits fluorescence when excited by an excitation light of any light intensity, but only exhibits a phototherapy effect at a sufficiently high light intensity. The fluorescent agent that has exhibited a phototherapy effect has a property that the molecular structure of the fluorescent molecule is broken and it no longer emits fluorescence. The measurement light L3 has a second intensity smaller than the first intensity, and is a weak light that does not cause the fluorescent agent to exhibit a phototherapy effect. In other words, the measurement light L3 is light obtained by attenuating the therapeutic light L2. For example, the first intensity is about 100 mW, and the second intensity is several nW. The measurement light L3 acts on both the unconsumed fluorescent agent that has previously accumulated in the affected area and the fluorescent agent that has reaccumulated in the affected area A and is not bound to the affected area A, generating fluorescence Lf as the sum of the fluorescence from the fluorescent agents in these two states.
[0046] The light detection unit 11 alternately detects the first fluorescence intensity F1 and the second fluorescence intensity F2 and outputs the fluorescence intensities F1, F2 to the calculation unit 14. The first fluorescence intensity F1 is the intensity of fluorescence Lf generated in the affected area A by irradiation with the therapeutic light L2, and is the intensity of fluorescence Lf generated by the fluorescent agent that has previously accumulated in the affected area A and the fluorescent agent that has reaccumulated in the affected area A. The second fluorescence intensity F2 is the intensity of fluorescence Lf generated in the affected area A by irradiation with the measurement light L3, and is the intensity of fluorescence generated by the fluorescent agent that has reaccumulated in the affected area A. In order for the calculation unit 14 to distinguish between the first fluorescence intensity F1 and the second fluorescence intensity F2, the first fluorescence intensity F1 and the second fluorescence intensity F2 are associated with the therapeutic light L2 and the measurement light L3, respectively.
[0047] The calculation unit 14 calculates the amount of change ΔF1 per unit time of the first fluorescence intensity F1 at that time point each time the light detection unit 11 detects the first fluorescence intensity F1, and calculates the amount of change ΔF2 per unit time of the second fluorescence intensity F2 at that time point each time the light detection unit 11 detects the second fluorescence intensity F2. ΔF1 and ΔF2 are calculated by the same method as ΔF in the first embodiment. Next, the calculation unit 14 calculates the degree of agreement between the amount of change ΔF1 and the amount of change ΔF2 as progress information. For example, the degree of agreement is expressed using the difference or ratio between ΔF1 and ΔF2, and the closer the difference between ΔF1 and ΔF2 is to zero, the higher the degree of agreement.
[0048] 8, when the phototherapy of the affected area A is completed, the change in the fluorescence intensity F1 of the affected area A is dominated by the change in the fluorescence intensity F2 of the re-accumulated fluorescent agent, so the change amount ΔF1 becomes equal or approximately equal to the change amount ΔF2. Therefore, as the phototherapy of the affected area A approaches completion, the degree of agreement becomes higher. The change amount ΔF1 and the change amount ΔF2 are amounts based on the light beams L2 and L3 of different intensities. Therefore, the change amounts ΔF1 and ΔF2 may be normalized so that the change amounts ΔF1 and ΔF2 are values obtained when the light beams L2 and L3 of the same intensity are irradiated, and the degree of match may be calculated using the normalized change amounts ΔF1 and ΔF2.
[0049] The determination unit 15 compares the degree of match with a predetermined threshold Th. If the degree of match is equal to or less than the threshold Th, the determination unit 15 outputs a determination result that the degree of match is equal to or less than the predetermined threshold Th. If the degree of match is greater than the threshold Th, the determination unit 15 outputs a determination result that the degree of match exceeds the predetermined threshold Th.
[0050] Next, the operation of the phototherapy system 200 and the phototherapy progress measurement device 20 will be described with reference to FIG. As in the first embodiment, the phototherapy progress measurement method shown in FIG. 9 is executed by the phototherapy progress measurement device 20 during phototherapy. The phototherapy progress measurement method includes step S21 of irradiating the affected area A with therapeutic light L2, step S22 of detecting a first fluorescent intensity F1, which is the intensity of fluorescence generated in the affected area A by irradiating the therapeutic light L2, step S24 of irradiating the affected area A with measurement light L3, step S25 of detecting a second fluorescent intensity F2, which is the intensity of fluorescence generated in the affected area A by irradiating the measurement light L3, steps S23, S26, and S27 of calculating progress information using the fluorescent intensities F1 and F2, and step S28 of determining whether the phototherapy on the affected area A has been completed based on the progress information.
[0051] After the start of phototherapy, the therapeutic light L2 and the measurement light L3 are alternately irradiated onto the affected area A (steps S21, S24), and the first fluorescent light intensity F1 and the second fluorescent light intensity F2 are alternately detected by the light detection unit 11 (steps S22, S25). The calculation unit 14 then calculates the amounts of change ΔF1, ΔF2 per unit time of the first fluorescent light intensity F1 and the second fluorescent light intensity F2 (steps S23, S26), and calculates the degree of agreement between the amounts of change ΔF1 and ΔF2 as progress information (step S27).
[0052] Next, the degree of agreement is compared with a predetermined threshold value Th by the judgment unit 15 (step S28). If the degree of agreement is equal to or less than the threshold value Th (NO in step S28), the judgment unit 15 judges that the degree of agreement is equal to or less than the predetermined threshold value Th, and notifies the doctor of the judgment result (step S10). After it is judged that the degree of agreement is equal to or less than the threshold value Th, steps S21 to S27 are repeated until it is judged that the degree of agreement exceeds the threshold value Th. If the degree of match is greater than the threshold Th (YES in step S28), the judgment unit 15 judges that the predetermined threshold Th has been exceeded, and notifies the doctor of this judgment result (step S13). Then, the therapeutic light adjustment unit 16 reduces the intensity of the therapeutic light L2 (step S14).
[0053] Thus, according to this embodiment, the second fluorescence intensity F2 of the fluorescent agent that reaccumulates in the affected area A during phototherapy is acquired as reference data. As the phototherapy approaches completion, the amount of change ΔF1 approaches the amount of change ΔF2, and the degree of agreement between the amount of change ΔF1 and the amount of change ΔF2 represents the accurate progress of the phototherapy on the affected area A. This degree of agreement can be calculated as progress information, and the accurate progress of the phototherapy can be measured. Furthermore, a doctor can accurately determine whether or not the phototherapy has been completed based on the progress information. In addition, the degree of coincidence is calculated in real time from the fluorescence intensities F1 and F2, which allows the doctor to measure the exact progress of the phototherapy in real time and determine in real time whether the phototherapy has been completed.
[0054] In this embodiment, the phototherapy progress measurement device 20 starts measuring the progress of phototherapy at the same time as the start of phototherapy. Alternatively, as in the first embodiment, the measurement of the progress of phototherapy may start when the amount of change ΔF1 becomes non-negative for the first time. That is, after the start of phototherapy, the calculation unit 14 calculates the amount of change ΔF1 each time the first fluorescent light intensity F1 is detected. The therapeutic light adjustment unit 16 controls the therapeutic light source 3 to output the therapeutic light L2 until the amount of change ΔF1 becomes non-negative for the first time from the start of phototherapy, and controls the therapeutic light source 3 to output the therapeutic light L2 and the measurement light L3 alternately after the amount of change ΔF1 becomes non-negative for the first time. According to this configuration, the therapeutic light L2 is irradiated onto the affected area A until the amount of change ΔF1 becomes negative for the first time, thereby shortening the treatment time for the affected area A.
[0055] In this embodiment, the therapeutic light L2 and the measurement light L3 are switched by changing the output of the therapeutic light source 3. Alternatively, the therapeutic light L2 may be switched by changing the irradiation distance of the therapeutic light L2 to the affected area A. The irradiation distance is the distance from the tip of the probe 4, from which the therapeutic light L2 is emitted, to the affected area A. The irradiation distance can be changed manually by a doctor by reciprocating the probe 4 in the longitudinal direction, or automatically by a motor (not shown) reciprocating the probe 4. By increasing the irradiation distance, the intensity of the therapeutic light L2 irradiated to the affected area A can be reduced, and the low-intensity therapeutic light L2 can be used as the measurement light L3. In this embodiment, a measurement light source that generates and outputs the measurement light L3 may be provided in addition to the treatment light source 3.
[0056] In the first and second embodiments, the display unit 6 may display progress information in addition to or instead of the determination result of the determination unit 15. For example, the display unit 6 may display, as the progress information, the integrated value I, the amounts of change ΔF1, ΔF2, and the numerical values of the degree of match, or may display a graph showing the changes over time.
[0057] Furthermore, the display unit 6 may display an indication showing the progress of the phototherapy for each affected area A as progress information superimposed on the endoscopic image. With this configuration, the doctor can easily grasp the progress of each affected area A based on the indication added to the affected area A in the endoscopic image. For example, each affected area A in an endoscopic image is labeled with one of "P1," "P2," "P3," or "P4." "P1" indicates a stage where the fluorescence intensity F is monotonically attenuating and phototherapy is progressing. "P2" indicates a stage where the change over time in the fluorescence intensity F is approximately zero and phototherapy has stopped progressing. "P3" indicates a stage where the fluorescence intensity F is increasing and both phototherapy and re-accumulation of the fluorescent agent are progressing. "P4" indicates a stage where the phototherapy has stopped progressing and only re-accumulation of the fluorescent agent is progressing.
[0058] In the first and second embodiments, the notification unit is the display unit 6 that displays the determination result of the determination unit 15, but instead of this, the notification unit may notify the determination result using other means. For example, the notification unit may output a sound according to the determination result. In the first and second embodiments, the phototherapy progress measurement device 10, 20 is a part of the endoscope system, but instead, it may be a device independent of the endoscope system. For example, the phototherapy progress measurement device 10, 20 may be a device separate from the endoscope processor 101, and may detect the fluorescence Lf of the affected area A and irradiate the affected area A with the measurement light L3 via a probe arranged outside the endoscope 1.
[0059] In the above-described embodiment, the reference data is either second fluorescence intensity data, which is the fluorescence intensity of the fluorescent agent that re-accumulates in the affected area during phototherapy, or preset data representing the change over time in the fluorescence intensity of the fluorescent agent due to irradiation with therapeutic light, not including the fluorescence intensity of the re-accumulating fluorescent agent. However, the reference data is not limited to the above, and may be other reference data as long as it is data determined in association with the fluorescence based on a fluorescent agent in an affected area not involved in phototherapy, which may be included in the fluorescence intensity at the end of phototherapy with the therapeutic light L2, based on the fluorescence intensity associated with a fluorescent agent in an affected area not involved in phototherapy. [Explanation of symbols]
[0060] 100,200 Phototherapy System 10,20 Phototherapy progress measuring device 3 Treatment light source 4. Probe (therapeutic light irradiation part) 6 Display section (notification section) 8 Image acquisition section 11 Light detection section 12 Intensity data generator 13 Storage section 14 Arithmetic section 15 Judgment section 16 Treatment light adjustment section A Affected area D1, D2, D3 preset data F, F1 First fluorescence intensity F2 Second fluorescence intensity ΔF, ΔF1, ΔF2 change amount I Accumulated value
Claims
1. A method for operating a phototherapy progress measurement device for measuring the progress of phototherapy using a fluorescent agent on an affected area, comprising: detecting a first fluorescence intensity, which is an intensity of fluorescence generated at the affected area as a result of irradiating the affected area with the therapeutic light, by a light detection unit; and a calculation unit that calculates progress information representing a progress of the phototherapy of the affected area using the first fluorescent intensity detected by the light detection unit and reference data related to the fluorescent agent, A method of operating a phototherapy progress measuring device, wherein the reference data is determined based on a fluorescence intensity associated with the fluorescent agent in the affected area not involved in the phototherapy.
2. The reference data is or second fluorescence intensity data, which is the intensity of the fluorescence of the fluorescent agent that reaccumulates in the affected area during the phototherapy; or 2. The method of claim 1, wherein the preset data represents a time change in the intensity of the fluorescence of the fluorescent agent caused by irradiation with the therapeutic light, the time change not including the intensity of the fluorescence of the fluorescent agent that reaccumulates.
3. The method further includes storing the first fluorescent intensity in a time series and generating intensity data representing a change in the first fluorescent intensity over time in an intensity data generating unit, Calculating the progress information by the calculation unit, selecting one preset data most similar to the intensity data as the reference data from among the plurality of preset data; calculating a corrected change amount per unit time of the first fluorescent intensity using the selected preset data; and calculating an integrated value of the amount of change per unit time of the first fluorescent intensity using the corrected amount of change; The method for operating a phototherapy progress measurement device according to claim 2, wherein the integrated value is the progress information.
4. irradiating the affected area with a measurement light weaker than the therapeutic light; and The method further includes detecting, by the light detection unit, the second fluorescence intensity, which is an intensity of fluorescence generated in the affected area by irradiating the affected area with the measurement light, calculating the progress information in the calculation unit includes calculating a degree of agreement between an amount of change per unit time of the first fluorescent intensity and an amount of change per unit time of the second fluorescent intensity, 3. The method of claim 2, wherein said degree of agreement is said progress information.
5. 5. The method of claim 4, wherein the irradiating of the measurement light includes switching the intensity of the therapeutic light irradiated to the affected area from a first intensity to a second intensity weaker than the first intensity by a therapeutic light adjustment unit that adjusts the intensity of the therapeutic light irradiated to the affected area, and the measurement light is the therapeutic light attenuated to the second intensity.
6. 6. The method for operating a phototherapy progress measurement device according to claim 5, wherein the intensity of the therapeutic light irradiated to the affected area is switched between the first intensity and the second intensity by switching an output of a therapeutic light source that outputs the therapeutic light using the therapeutic light adjustment unit.
7. 6. The method for operating a phototherapy progress measurement device according to claim 5, wherein an intensity of the therapeutic light irradiated to the affected area is switched between the first intensity and the second intensity by changing an irradiation distance of the therapeutic light to the affected area by the therapeutic light adjustment unit.
8. The method further includes determining whether or not an amount of change in the first fluorescent intensity per unit time is negative by the calculation unit, The method for operating a phototherapy progress measurement device according to claim 1 , wherein the calculation of the progress information by the calculation unit is performed after it is determined that the amount of change is not negative.
9. The method for operating the phototherapy progress measurement device according to claim 1 , further comprising: determining, by a determination unit, whether or not the phototherapy of the affected area has been completed based on the progress information.
10. A processor for measuring the progress of a phototherapy of an affected area with a fluorescent agent, a light detection unit that detects a first fluorescence intensity, which is an intensity of fluorescence generated at the affected area when the therapeutic light is irradiated to the affected area; a calculation unit that calculates progress information representing a progress of phototherapy on the affected area using the first fluorescent light intensity and reference data, A processor, wherein the reference data is determined based on a fluorescence intensity associated with the fluorescent agent in the affected area not involved in the light treatment.
11. The reference data is data of a second fluorescence intensity, which is the intensity of the fluorescence of the fluorescent agent that reaccumulates in the affected area during the phototherapy, or The processor according to claim 10 , wherein the preset data represents a time change in the intensity of the fluorescence of the fluorescent agent caused by irradiation with the therapeutic light, the time change not including the intensity of the fluorescence of the fluorescent agent that reaccumulates.
12. an intensity data generating unit that stores the first fluorescent intensity in chronological order and generates intensity data that represents a change over time in the first fluorescent intensity; A storage unit that stores a plurality of the preset data, The calculation unit, selecting one preset data most similar to the intensity data as the reference data from among the plurality of preset data; correcting the correction change amount per unit time of the first fluorescent intensity using the selected preset data; The processor according to claim 11 , wherein an integrated value of an amount of change per unit time of the first fluorescent intensity is calculated using the corrected amount of change, and the integrated value is the progress information.
13. the light detection unit further detects the second fluorescence intensity, which is an intensity of fluorescence generated at the affected area when the affected area is irradiated with measurement light that is weaker than the therapeutic light; The processor according to claim 11 , wherein the calculation unit calculates a degree of agreement between an amount of change per unit time of the first fluorescent intensity and an amount of change per unit time of the second fluorescent intensity, the degree of agreement being the progress information.
14. a therapeutic light adjusting unit for adjusting an intensity of the therapeutic light irradiated to the affected area, 14. The processor according to claim 13, wherein the therapeutic light adjustment unit switches an intensity of the therapeutic light irradiated to the affected area between a first intensity and a second intensity weaker than the first intensity, and the measurement light is the therapeutic light attenuated to the second intensity.
15. The calculation unit is determining whether the amount of change in the first fluorescent intensity per unit time is negative; The processor of claim 10 , further comprising: a processor for calculating the progress information after determining that the amount of change is not negative.
16. The processor according to claim 10 , further comprising a determination unit that determines whether or not phototherapy of the affected area has been completed based on the progress information.
17. A phototherapy system for irradiating an affected area with therapeutic light and phototherapy the affected area with a fluorescent drug, comprising: a therapeutic light source that outputs the therapeutic light; a therapeutic light irradiator for irradiating the affected area with the therapeutic light; A processor according to claim 16; A phototherapy system comprising: a notification unit that notifies the determination result of the determination unit of the processor.
18. a therapeutic light adjusting unit for adjusting an intensity of the therapeutic light irradiated to the affected area, The phototherapy system according to claim 17 , wherein when the determining unit determines that the phototherapy on the affected area is completed, the therapeutic light adjusting unit reduces an intensity of the therapeutic light.
19. an image acquisition unit for acquiring an image of the affected area; a display unit that displays the image acquired by the image acquisition unit, The phototherapy system of claim 17 , wherein the display displays the progress information.
20. The phototherapy system of claim 19 , wherein the display unit displays the progress information superimposed on the affected area in the image.
Citation Information
Patent Citations
Cancer treatment state evaluation method and device and cancer treatment method and apparatus
JP2006167046A
Evaluation device and evaluation method
JP2011212423A
Apparatus and methods to monitor photodynamic therapy (PDT)
WO1999006113A1
System and method for interstitial photodynamic light therapy in combination with photosensitizers
WO2012076631A1
Cited By
Light treatment progress measurement method, light treatment progress measurement device, and light treatment system
CN117222449A
